FinancialContent is the trusted provider of stock market information to the media industry.
Bristol-Myers Squibb to Take Part in Goldman Sachs 39th Annual Global Healthcare Conference

Bristol-Myers Squibb Company (NYSE: BMY) will take part in Goldman Sachs 39th Annual Global Healthcare Conference on Wednesday, June 13, 2018, in Rancho Palos Verdes, CA. Johanna Mercier, Head of U.S. Commercial, and Fouad Namouni, Head of Oncology Development, will answer questions about the company at 6:20 p.m. ET (3:20 p.m. PT).

Investors and the general public are invited to listen to a live webcast of the session at An archived edition of the session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at or follow us on LinkedInTwitter, YouTube and Facebook.


Bristol-Myers Squibb
Ken Dominski, 609-252-5251
Tim Power, 609-252-7509
Bill Szablewski, 609-252-5894
Related Stocks:
Data & News supplied by
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Financial Widgets

Display market data, financial news or stock quotes - Learn More

Advertising Network

Advertise on FinancialContent's huge network - Learn More

Web Services

Power your internet and wireless applications - Learn More